Healthcare -
Biotechnology - NASDAQ - US
$ 1.32
6.3 %
$ 841 M
Market Cap
-5.0
P/E
GERN - RESEARCH & DEVELOPMENT
Research & Development GERN - Geron Corporation
104 M
LAST VALUE
4.21%
2 YEAR CAGR
14.78%
5 YEAR CAGR
17.48%
10 YEAR CAGR